Infliximab biosimilar-to-biosimilar switching in 1,605 patients with inflammatory rheumatic diseases: Clinical outcomes in real-world patients from the DANBIO registry

  • Hafsah Nabi (Speaker)
  • Merete Lund Hetland (Co-author)
  • Hendricks, O. (Co-author)
  • Dorte Vendelbo Jensen (Co-author)
  • Pedersen, J. K. (Co-author)
  • Just, S. A. (Co-author)
  • K. Danebod (Co-author)
  • Munk, H. L. (Co-author)
  • S. Kristensen (Co-author)
  • Natalia Manilo (Co-author)
  • Ada Colic (Co-author)
  • Asta Linauskas (Co-author)
  • P H Thygesen (Co-author)
  • L. B. Christensen (Co-author)
  • Maren Høgberget Kalisz (Co-author)
  • N. Lomborg (Co-author)
  • Jolanta Grydehøj (Co-author)
  • Johnny Lillelund Raun (Co-author)
  • R Ahmed (Co-author)
  • Frank Mehnert (Co-author)
  • Niels Steen Krogh (Co-author)
  • Bente Glintborg (Co-author)

Activity: Talks and presentationsConference presentations

Period1. Jun 2022
Event titleEULAR European Congress in Rheumatology 2022
Event typeConference
Degree of RecognitionInternational